On Jan. 4 it was announced that the Crohn’s & Colitis Congress will be a fully virtually experience.
Bethesda, MD (December 13, 2021) – The Crohn’s & Colitis Congress®, the premier conference for inflammatory bowel diseases (IBD) health care providers and researchers, invites media to virtually attend the 2022 meeting.
A partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA), the Congress will disseminate the latest research and care strategies to ultimately improve the lives of the estimated three million Americans living with IBD, which include Crohn’s disease and ulcerative colitis.
When: Jan. 20-22, 2022
Why: The Crohn’s & Colitis Congress aims to transform IBD care by bringing together more than 1,300 IBD health care providers and researchers to discuss trends in IBD patient care. The most advanced, cutting-edge research will be presented, providing insights into new therapeutics and treatment options. Experts in the field will present and lead discussions designed to improve the health and quality of life of IBD patients.
- Pre-meeting news: Prior to the meeting, the Crohn’s & Colitis Foundation and AGA will share embargoed data to be presented during the Congress with registered media and can facilitate pre-meeting interviews with investigators and IBD thought leaders.
- Virtual access to experts: Leading IBD experts will be available to engage with reporters virtually. For a diverse perspective on the science presented at the meeting, we can also connect you with our patient speakers. Noteworthy sessions include:
- Breaking the ceiling of IBD therapies
- Personalized medicine in IBD
- Microbiota and dietary influences in intestinal health and inflammation
- Technology: changing IBD care
Register: Contact Courtney Reed at firstname.lastname@example.org to register, request to be added to the pre-meeting news media list or with any additional questions. There is no cost for media and bloggers to register.
Learn more about IBD:
About the Crohn’s & Colitis Congress®
The Crohn’s & Colitis Congress® taking place from Jan. 20-22, 2022, combines the strengths of the nation’s leading IBD patient organization, Crohn’s & Colitis Foundation, and the premier GI professional association, American Gastroenterological Association (AGA). Together we are committed to convening the greatest minds in IBD to transform patient care. The Crohn’s & Colitis Congress is the must-attend meeting for all IBD professionals. Learn more at crohnscolitiscongress.org.
About the Crohn’s & Colitis Foundation
The Crohn’s & Colitis Foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel diseases (IBD). The Foundation’s mission is to cure Crohn’s disease and ulcerative colitis, and to improve the quality of life for the estimated 3 million Americans living with IBD. For over 50 years, we have been inspiring and engaging patients and caregivers in the country’s largest IBD community and helping to dramatically accelerate the pace of research by breaking down traditional barriers to patients, data, funding, and collaborations. We also provide extensive educational resources for patients and their families, medical professionals, and the public. For more information, visit www.crohnscolitisfoundation.org, call 888-694-8872, or email email@example.com.
LinkedIn: Crohn’s and Colitis Foundation
About the AGA Institute
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA has grown to more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org.
Like AGA on Facebook.
Follow us on Twitter @AmerGastroAssn